Zhang S, Zhang Y, Chen T, Hu H, Lu C
Cells. 2025; 14(5).
PMID: 40072111
PMC: 11898529.
DOI: 10.3390/cells14050383.
Felicio D, Martins S, Alves G, Amorim A, Macedo-Ribeiro S, Merski M
Protein Sci. 2024; 33(12):e5236.
PMID: 39589068
PMC: 11590126.
DOI: 10.1002/pro.5236.
Beretta G, Costantino M, Mirra L, Pettinari P, Perego P
Int J Biol Sci. 2024; 20(13):5208-5222.
PMID: 39430244
PMC: 11489175.
DOI: 10.7150/ijbs.100355.
Hernandez-Carralero E, Quinet G, Freire R
Expert Rev Mol Med. 2024; 26:e19.
PMID: 39320846
PMC: 11440613.
DOI: 10.1017/erm.2024.10.
Li L, Wang M, Huang L, Zheng X, Wang L, Miao H
Discov Oncol. 2024; 15(1):298.
PMID: 39039334
PMC: 11263328.
DOI: 10.1007/s12672-024-01158-y.
The polyglutamine protein ATXN2: from its molecular functions to its involvement in disease.
Costa R, Conceicao A, Matos C, Nobrega C
Cell Death Dis. 2024; 15(6):415.
PMID: 38877004
PMC: 11178924.
DOI: 10.1038/s41419-024-06812-5.
The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
Potapenko A, Davidson J, Lee A, Laird A
Biochem J. 2024; 481(6):461-480.
PMID: 38497605
PMC: 11088879.
DOI: 10.1042/BCJ20240017.
ATXN2 is a target of N-terminal proteolysis.
Chitre M, Emery P
PLoS One. 2023; 18(12):e0296085.
PMID: 38128014
PMC: 10735043.
DOI: 10.1371/journal.pone.0296085.
Pbp1 associates with Puf3 and promotes translation of its target mRNAs involved in mitochondrial biogenesis.
van de Poll F, Sutter B, Acoba M, Caballero D, Jahangiri S, Yang Y
PLoS Genet. 2023; 19(5):e1010774.
PMID: 37216416
PMC: 10237644.
DOI: 10.1371/journal.pgen.1010774.
TR-FRET-Based Immunoassay to Measure Ataxin-2 as a Target Engagement Marker in Spinocerebellar Ataxia Type 2.
Bux J, Sen N, Klink I, Hauser S, Synofzik M, Schols L
Mol Neurobiol. 2023; 60(6):3553-3567.
PMID: 36894829
PMC: 10122633.
DOI: 10.1007/s12035-023-03294-y.
Towards Personalized Allele-Specific Antisense Oligonucleotide Therapies for Toxic Gain-of-Function Neurodegenerative Diseases.
Helm J, Schols L, Hauser S
Pharmaceutics. 2022; 14(8).
PMID: 36015334
PMC: 9416334.
DOI: 10.3390/pharmaceutics14081708.
Targeting the VCP-binding motif of ataxin-3 improves phenotypes in Drosophila models of Spinocerebellar Ataxia Type 3.
Johnson S, Libohova K, Blount J, Sujkowski A, Prifti M, Tsou W
Neurobiol Dis. 2021; 160:105516.
PMID: 34563642
PMC: 8693084.
DOI: 10.1016/j.nbd.2021.105516.
The Role of Methionine Residues in the Regulation of Liquid-Liquid Phase Separation.
Aledo J
Biomolecules. 2021; 11(8).
PMID: 34439914
PMC: 8394241.
DOI: 10.3390/biom11081248.
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.
Snyder N, Silva G
J Biol Chem. 2021; 297(3):101077.
PMID: 34391779
PMC: 8424594.
DOI: 10.1016/j.jbc.2021.101077.
Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.
Singh A, Hulsmeier J, Kandi A, Pothapragada S, Hillebrand J, Petrauskas A
Elife. 2021; 10.
PMID: 33689682
PMC: 7946432.
DOI: 10.7554/eLife.60326.
The RNA-Binding Protein ATXN2 is Expressed during Megakaryopoiesis and May Control Timing of Gene Expression.
Hansen M, Zeddies S, Meinders M, Di Summa F, van Alphen F, Hoogendijk A
Int J Mol Sci. 2020; 21(3).
PMID: 32024018
PMC: 7037754.
DOI: 10.3390/ijms21030967.
Disruption of valosin-containing protein activity causes cardiomyopathy and reveals pleiotropic functions in cardiac homeostasis.
Brody M, Vanhoutte D, Bakshi C, Liu R, Correll R, Sargent M
J Biol Chem. 2019; 294(22):8918-8929.
PMID: 31006653
PMC: 6552413.
DOI: 10.1074/jbc.RA119.007585.
Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1.
Wang X, Huang X, Yao J, Wang C, Xia Q, Long X
Oncotarget. 2018; 9(44):27321-27332.
PMID: 29937988
PMC: 6007954.
DOI: 10.18632/oncotarget.24535.
Toxicity and aggregation of the polyglutamine disease protein, ataxin-3 is regulated by its binding to VCP/p97 in Drosophila melanogaster.
Ristic G, Sutton J, Libohova K, Todi S
Neurobiol Dis. 2018; 116:78-92.
PMID: 29704548
PMC: 7721245.
DOI: 10.1016/j.nbd.2018.04.013.
Analysis of (CAG) expansion in ATXN1, ATXN2 and ATXN3 in Chinese patients with multiple system atrophy.
Zhou X, Wang C, Ding D, Chen Z, Peng Y, Peng H
Sci Rep. 2018; 8(1):3889.
PMID: 29497168
PMC: 5832826.
DOI: 10.1038/s41598-018-22290-0.